Tofacinix 11 MG & Tofacitinib Cost – 30 TABLETS

Name: Tofacinix 11 MG (Tofacitinib) – 30 Tablets
Brand: Tofacinix 11 MG (Tofacitinib)
Price: 90 $
Availability: InStock

Tofacitinib

$ 90.00

Tofacinix 11 mg (Tofacitinib) is a JAK inhibitor used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Typically taken once daily, its dosage may vary based on medical history and condition severity. While effective, it carries risks of serious infections and other side effects like hypertension and elevated liver enzymes. Pregnant and nursing women should exercise caution. Store below 25°C and keep out of reach of children. Available for worldwide delivery, including the USA, UK, and many other countries.

Categories: Alopecia areata, Arthritis Tags: Tofacinix 11 MG, Tofacinix 11 MG & Tofacitinib Cost, Tofacitinib Cost

Description

Tofacinix 11 MG & Tofacitinib Cost

We explore the Tofacinix 11 MG & Tofacitinib Cost. Tofacitinib 11 mg is a specific dosage strength of the medication Tofacitinib. Tofacitinib is a janus kinas (JAK) inhibitor. It is use for autoimmune conditions, Like rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and ankylosing spondylitis, among others. In this Content we will learn about Tofacinix 11 mg & Tofacitinib cost.

Tofacinix 11 MG & Tofacitinib Cost

Quantity: 30

Price (USD): $90.00

Recommended Tofacitinib Dosage

The Tofacitinib 11 mg dosage varies based on the specific autoimmune condition and a patient’s medical history. It’s crucial to follow your healthcare provider’s dosage and instructions. This tablet is take once a day

Rheumatoid Arthritis: You can take 5 mg twice a day. Some may need 11 mg once daily depending on severity and response.

Psoriatic Arthritis: the usual starting dose is 5 mg twice daily (10 mg daily), with some needing 11 mg once daily, similar to rheumatoid arthritis

Ulcerative Colitis

The recommended starting dose for adults is often tofacitinib 10 mg taken orally twice daily for induction for 8 weeks and 11 mg given once daily for maintenance.
For patients who do not achieve adequate therapeutic benefit by week 8, the induction dose of 10 mg twice daily can extend for an additional 8 weeks (16 weeks total), followed by 11 mg once daily for maintenance. Tofacinix 11 mg (Tofacitinib) induction therapy should discontinue in any patient who shows no evidence of therapeutic benefit by week 16.
Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is half the total daily dose.

Warnings And Precautions

Serious and sometimes life-threatening infections have been reported in patients who are undergoing treatment with Tofacitinib. These infections can be caused by various pathogens, including bacteria, mycobacteria, invasive fungi, viruses, and other opportunistic microorganisms. Among the most frequently observed serious infections associated with Tofacitinib use are pneumonia, cellulitis, herpes zoster (shingles), urinary tract infections, diverticulitis, and appendicitis.

Tofacinix can cause various infections, including tuberculosis, cryptococcosis, histoplasmosis, esophageal candidiasis, pneumocystosis, multidermatomal herpes zoster, cytomegalovirus infections, BK virus infection, and listeriosis.

It’s worth noting that some patients have developed disseminated infections rather than localized ones. This has occurred more frequently in individuals who were also taking other immunomodulating drugs like methotrexate or corticosteroids alongside Tofacitinib.

In the case of patients with ulcerative colitis (UC), caution should be exercised when considering the use of Tofacinix. It is advisable to avoid Tofacinix in individuals with active and serious infections, including those that are localized. Before initiating Tofacitinib treatment, healthcare providers should carefully evaluate the potential risks and benefits, especially in patients who have:

Chronic or recurrent infections.
Been exposed to tuberculosis.
Suffered from serious or opportunistic infections.
Resided in or traveled to areas where tuberculosis or endemic fungal infections are prevalent.
Underlying medical conditions that may make them more susceptible to infections.

Always follow your doctor’s instructions and attend regular check-ups while closely monitor for the development of signs and symptoms of infection during and after treatment with Tofacinix 11 MG.

Side Effects

Most common side effects are:

Upper respiratory tract infections
Headache
High blood pressure (hypertension)
Increased levels of liver enzymes
Nausea
Diarrhea
Changes in blood cell counts
Elevated levels of cholesterol and triglycerides
Skin rash
Elevated creatinine levels (a marker of kidney function)

Pregnancy and Lactation

Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Tofacinix uses during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution exercised when this product administered to a nursing woman.

Overdose

There is no specific antidote for overdose with Tofacinix 11 MG. In case of an overdose, it recommends that the patient monitor for signs and symptoms of adverse reactions.

Storage Condition

Store Tofacinix (Tofacitinib) below 25°C. Do not remove desiccant. Dispense in the original container. Keep it out of the reach and sight of children.

How Supplied

Tofacinix tablet: Each HDPE container of Tofacinix contains 60 tablets, a silica gel desiccant, and a polyester coil with a child-resistant closure.

Tofacinix 11 MG & Tofacitinib Cost is very affordable in this website.

The country where our services are provided

Delivering worldwide including United State (USA), United Kingdom (UK), Saudi Arabia, Dubai, Kuwait, Qatar, Philippines, Nepal, Malaysia, Indonesia, Thailand, Poland, Peru, South Korea, New Zealand, Netherlands, Georgia, France, Egypt, Australia, Germany, Canada, Uzbekistan, Lebanon, Mexico, Singapore, Vietnam

If you want to know more information about Tofacitinib

Please Visit: